In vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
Methicillin-Resistant Staphylococcus aureus
1989 • 981 citations
Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
1987 • 594 citations
WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
1989 • 320 citations
Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital
1989 • 176 citations
Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones
1989 • 124 citations
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital
1990 • 96 citations
Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections
1989 • 86 citations
Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations
1989 • 83 citations
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates
1991 • 58 citations
Activity of new quinolones against ciprofloxacin-resistant staphylococci
1991 • 46 citations
Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin
1991 • 23 citations
In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria
1990 • 18 citations
The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
1988 • 11 citations